Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Amdipharm UK Limited, Capital House, 85 King William Street, London, EC4N 7BL, United Kingdom
Apresoline Ampoules 20 mg.
Hydralazine 20mg Powder for Concentrate for Solution for Injection/Infusion.
| Pharmaceutical Form |
|---|
|
Ampoules containing powder for concentrate for solution for injection/infusion. White to yellow lyophilisate (pellet). |
The active ingredient is 1-hydralainophthalazine hydrochloride (hydralazine hydrochloride). Each 2 ml ampoule contains 20mg hydralazine hydrochloride.
Excipient(s) with Known effect: For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Hydralazine |
Hydralazine is a direct acting vasodilator which exerts its effects principally on the arterioles. Its precise mode of action is not known. |
| List of Excipients |
|---|
|
Hydrochloric acid |
Colourless Type I glass 2ml ampoule. Five ampoules are packed in a cardboard printed carton.
Amdipharm UK Limited, Capital House, 85 King William Street, London, EC4N 7BL, United Kingdom
PL 20072/0230
15 November 2001
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
